StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS - Free Report) in a research note issued to investors on Saturday. The firm issued a hold rating on the stock.
Separately, Benchmark restated a "speculative buy" rating and set a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.
Read Our Latest Report on MLSS
Milestone Scientific Stock Performance
Shares of NYSE:MLSS traded up $0.05 during midday trading on Friday, hitting $0.88. 238,981 shares of the stock were exchanged, compared to its average volume of 117,502. Milestone Scientific has a 52-week low of $0.52 and a 52-week high of $1.10. The business's fifty day simple moving average is $0.81 and its two-hundred day simple moving average is $0.86. The company has a market capitalization of $68.54 million, a PE ratio of -12.57 and a beta of 1.10.
Insider Transactions at Milestone Scientific
In other news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now owns 4,606,882 shares of the company's stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 24.75% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC boosted its stake in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock valued at $480,000 after purchasing an additional 31,572 shares during the period. World Investment Advisors LLC acquired a new position in shares of Milestone Scientific during the third quarter worth approximately $91,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific in the third quarter valued at approximately $48,000. 5.79% of the stock is currently owned by institutional investors and hedge funds.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Articles
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
